Alveo Technologies Announces Major Distribution Expansion Across EMEA
19 distributors signed, demonstrating strong interest and momentum for its molecular detection platform, which provides a foundation for rapid, accurate, point-of-need pathogen testing across Human In Vitro Diagnostics, Agricultural, and Bioindustrial markets
Alameda, Calif. - December 13, 2023 - Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced 19 new distributor partnerships across Europe, Africa, and the Middle East (EMEA). These new partnerships expand its global reach to support Alveo's 2024 product launches and to fulfill demand for its current COVID-19 product already on the market.
The new distribution partnerships include:
Europe
• Biosan (Hungary)
• Farmas (North Macedonia, Albania, Kosovo)
• Hydrox (Lithuania, Latvia, Estonia)
• InterPharm (Montenegro)
• MD Solutions (Serbia)
• OK SERVIS Biopro (Czech Republic, Slovakia)
• Synmed Bulgaria Ltd (Bulgaria)
• Synmedom (Romania)
• Syntec Scientific Ltd (Ireland)
• Techtum Lab AB (Sweden)
Middle East
• Al Hayat Pharmaceutical (United Arab Emirates)
• Al Suwaidi (Qatar)
• Bioteck (Lebanon)
• Genetics Code (Jordan)
• Ideal Medical Company Limited (Saudi Arabia)
• Ultra Diagnostic (Egypt)
Featured Product
Compressed Air Open Blowing White Paper
Compressed air is a limited resource that is generated in-house for the benefit of many operations within the manufacturing environment. Learn how to ensure all point of use applications are using your compressed air in the most effective and efficient way possible. Learn how much it costs to produce that compressed air and how Engineered Nozzles can help you use your air more effectively and efficiently.
